Moderna, Inc. is reported to be planning to price its COVID-19 vaccine at $50 to $60 per two-part treatment, a much higher level than indicated by other frontrunners.
The Financial Times reported on 28 July that the US biotech is considering pricing its as-yet-unapproved mRNA-1273 at $25-30 a...






